Reaching the milestone of treating 100,000 patients with the Lapiplasty 3D Bunion Correction System demonstrates the product's effectiveness and acceptance in the market. This achievement is likely to boost investor confidence, potentially leading to an increase in stock price as it reflects positively on the company's revenue prospects and market position.